Literature DB >> 6223406

Effects of crosslinking on the rigidity and proteolytic susceptibility of human fibrin clots.

J A Gladner, R Nossal.   

Abstract

Clots formed in reconstituted human plasma or from purified human fibrin were studied in order to assess the effects of subunit crosslinking on clot strength and on resistance to plasmin degradation. The relative amounts of alpha chain and gamma chain ligation were varied by adding factor XIII to the samples. We observe, as have others, that appreciable gamma-gamma crosslinking always precedes detectable formation of alpha dimer or alpha polymer. Non-invasive light scattering measurements of the shear modulus G(t) indicate that ligation of gamma chains and of alpha chains have qualitatively similar effects on clot strength. Since alpha crosslinking occurs very slowly in the clots which are formed from plasma, we infer that under physiological conditions the involvement of alpha chains in the development of clot strength probably is only a secondary function. Light scattering techniques also were used to study the size of particles shed from the surfaces of fibrin clots undergoing fibrinolysis, and no differences could be discerned as resulting from ligation of alpha chains.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223406     DOI: 10.1016/0049-3848(83)90081-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  Compressive mechanical properties of the intraluminal thrombus in abdominal aortic aneurysms and fibrin-based thrombus mimics.

Authors:  John H Ashton; Jonathan P Vande Geest; Bruce R Simon; Darren G Haskett
Journal:  J Biomech       Date:  2008-12-05       Impact factor: 2.712

2.  Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology.

Authors:  E A Ryan; L F Mockros; A M Stern; L Lorand
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

3.  Structural origins of fibrin clot rheology.

Authors:  E A Ryan; L F Mockros; J W Weisel; L Lorand
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

4.  Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.

Authors:  C W Francis; V J Marder
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

5.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.

Authors:  V C Yee; L C Pedersen; I Le Trong; P D Bishop; R E Stenkamp; D C Teller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation.

Authors:  Bijan Ahvazi; Hee Chul Kim; Sun-Ho Kee; Zoltan Nemes; Peter M Steinert
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

7.  Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.

Authors:  C Tran-Thang; E K Kruithof; F Bachmann
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

8.  Functional factor XIII-A is exposed on the stimulated platelet surface.

Authors:  Joanne L Mitchell; Ausra S Lionikiene; Steven R Fraser; Claire S Whyte; Nuala A Booth; Nicola J Mutch
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

9.  Substrate specificity of microbial transglutaminase as revealed by three-dimensional docking simulation and mutagenesis.

Authors:  Uno Tagami; Nobuhisa Shimba; Mina Nakamura; Kei-Ichi Yokoyama; Ei-Ichiro Suzuki; Takatsugu Hirokawa
Journal:  Protein Eng Des Sel       Date:  2009-10-22       Impact factor: 1.650

Review 10.  Inhibition of Fibrinolysis by Coagulation Factor XIII.

Authors:  Dingeman C Rijken; Shirley Uitte de Willige
Journal:  Biomed Res Int       Date:  2017-07-06       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.